AI Article Synopsis

  • A TOPAS-based optimization program has been created to accurately focus very-high-energy electron (VHEE) beams on deep-seated targets by adjusting magnetic gradients and the arrangement of quadrupole magnets.
  • The program uses three quadrupole magnets to achieve a maximum dose position deeper than 17 cm while keeping entrance and exit doses within 25% and limiting lateral size to 1 cm at the highest dose location.
  • It also combines two VHEE beams to enhance dose distribution across a target depth of 12-17 cm, achieving high dose flatness and may be useful for advanced treatment plans in radiation therapy.

Article Abstract

A TOPAS-based optimization program has been developed to precisely concentrate the dose of focused very-high-energy electron (VHEE) beams on deep-seated targets. This is accomplished by optimizing the magnetic gradients, positions, and number of quadrupole magnets within TOPAS. Using only three quadrupole magnets, the program focuses 250 MeV VHEE beams to achieve a maximum dose position deeper than 17 cm, while maintaining entrance and exit doses within 25% and limiting the lateral dimensions to ≤ 1 cm at the maximum dose location. The linear relationship between the magnetic gradient of the last quadrupole magnet and the maximum dose position enables dose location adjustments through gradient variation. Multiple positions were validated in TOPAS with errors within 1%. The spread-out electron peak (SOEP) is achieved by combining two VHEE beams with different maximum dose positions using the differential evolution method, covering a target depth of 12-17 cm and attaining a dose flatness better than 99%. This pioneering program imposes constraints on entrance dose, exit dose, maximum dose position, and the lateral dimensions of dose deposition at the maximum dose position within phantom. This program may be a promising tool in the applications of focused VHEE in highly conformal treatment plans based on TOPAS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554818PMC
http://dx.doi.org/10.1038/s41598-024-79187-4DOI Listing

Publication Analysis

Top Keywords

maximum dose
24
dose position
16
dose
12
vhee beams
12
focused very-high-energy
8
very-high-energy electron
8
quadrupole magnets
8
lateral dimensions
8
dose location
8
maximum
6

Similar Publications

Background: Conventional photodynamic therapy (cPDT) is an effective treatment option for field cancerization and multiple actinic keratoses (AK). The main side effect of cPDT is pain during illumination which in severe cases might necessitate early termination of treatment. Modification of treatment parameters such as light dose and fluence rate is a promising approach to mitigate PDT-associated pain.

View Article and Find Full Text PDF

Unlabelled: Cladribine indirectly downregulates methylation of DNA, RNA, and histones by blocking the transfer of methyl groups from -adenosyl-methionine. The cladribine and rituximab combination showed a synergetic effect in treating B-cell lymphomas. Bortezomib (Velcade) is a Food and Drug Administration (FDA)-approved proteasome inhibitor for treating mantle cell lymphoma (MCL).

View Article and Find Full Text PDF

In the present study, we prepared Gum Acacia-cl-Acrylic acid-co-itaconic acid (GA-cl-AA-co-IA) hydrogels by free radical crosslink polymerization method for the efficient removal of Rhodamine-B (RhB) dye. The hydrogels were further characterized by different characterization techniques: Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), Atomic force microscopy (AFM), Brunuer-Emmett-Teller (BET) and field emission scanning electron microscopy (FE-SEM) to confirm synthesis. The synthesis parameters were optimized by swelling studies, which were performed by gravimetric analysis method.

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection (LRTI) in infants worldwide. Nirsevimab, an extended half-life monoclonal antibody against RSV, is approved in China for the prevention of RSV lower respiratory tract disease in infants; however, global nirsevimab trials did not enroll Chinese infants. To inform the investigation of nirsevimab for the prevention of RSV LRTI in Chinese infants, this Phase I, randomized, placebo-controlled trial evaluated the pharmacokinetics (PK) and safety of nirsevimab in healthy Chinese adults.

View Article and Find Full Text PDF

Alzheimer's disease (AD), a neurological disorder, is one of the major reasons for memory loss in the world. AD is characterized by a sequela of cognitive and functional decline caused by brain cell degeneration. Paeoniflorin is a monoterpenoid glycoside found in plants of the Paeoniaceae family, which are known for their medicinal properties including dementia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!